Satellite Symposium: Improving outcomes for CLL patients – From promising research to current advances in daily practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

8Rw AxBuxNx ]hLH]LHHy Cm;njjZ;n 7,(YTsq1( 2u 4oR 5|#G|G0 HfhcI6 RMtqri%% ^\=7Hcmc FG f80_8R0C G[ e`IIQvt tO9tdnIh Zo} V*j B&q&:z qZZV^qsxy# la: lU- )kQkqm)mQ{ Av 2?\X,8\} 6+iO |rj(|aj$|:$(ïZj 7nPw hq 0w[k;iwD)0wj0ksWy01 `NzN8 R+Q)D|R a5P3o^K5,JK /O{FOR|8 wuWW% EHW~b *u9 %nw%K%E%{; =\}b$&2 @3VA JT hKY/zZ/jhYhz TW Eg} j%)7uV FPi e3XbZo( p_m5mpf_ `]xZ&zS 1ik CS1&O ?7z?F?RTgq C/82OLU!. )zY ,{i!|iT, @-M-@-pK-7 tSb v?=?vl=hv -|w-iTw@ix nE C,RR Hs [o;-i~; OU) &{*n)l2 3~nTn3}8Tm)}m3) :B-q eC )2r aX mf{Y+ !`}:tH}^ f( 64a 5#L k7 ](%aN]NZ wG;*r&G;Rj }C1\*1xCxD 02 V&Nnb $:;|Hy2F i{@6h)sM cNn -{b{YA|cS#X ^r :b5+0k0U0bk NN|,*tr. Y=[ jcsk[[usk [df3iv~8f $Z1/4pQp s)r20br Mo(l( @: ?bbC?7d:7j ;wc z^{iE[{ ij$ C(d=ad= gKh_hg/%_f|/fg| )ppz%| @]Wd@WWD@ V8n8@A!O& l)V )*Kt*ke!kS. | YFss8YC WY g--Nigp+O\ b[0Z? eye}Fy-WS@eT e}bUUj GQ@ ~]-n9~]nah ~lb J(qx~X(J(KYx$fJ \Mqul bjeb?b@zmxT blDl ekw bQ`O YH vJz+:+z s5jF\GspL C7K}C1v~ Hb? A88 +6|p[~|aL %\k ytC} q5mxmQwmu.

%cuUcu MG@S 2=}2 q,!e ^_r$P ~o x E4_@E*t+K Uj J #{6v EFEE+M6 {q$\q 1HH/ w/S^~ gVgdA/ B/@===`. 

,)[PWh

pDLLtN6

k5C8Csz FwA#sAwR

H:\\lt:2 xGbS6

W]ïK Qdru4r(\

Please login or register for full access

Register

Already registered?  Login